Ashford Benjamin is a specialist executive search firm, focusing on legal recruitment and compliance recruitment in Hong Kong and Asia-Pacific, with a global reach...
Our expert advisors have a long history of placing lawyers into high-profile legal jobs in Hong Kong and Asia-Pacific, including private practice jobs and legal counsel jobs
Our team place Head of Compliance jobs and Chief Compliance Officer jobs in Hong Kong and Asia-Pacific, into financial services, and multi-national companies...
Our expert advisors are highly-qualified, experienced professionals who have been recognised as industry leaders in both legal and compliance recruitment...
Ben is not only a subject matter expert but someone who sees things from both sides of the table. Due to his legal industry background he speaks the same language as both his candidates and clients alike, and not only fundamentally understands the roles that he works on but also understands the pressures and challenges that clients and candidates face throughout the process. He also has the ability to face off effectively with HR due to his deep understanding of the recruitment process. Someone with integrity and a commercial mindset, a high level and trustworthy operator and someone that I wouldn't hesitate to recommend.
Top Tier Global Investment Bank, Hong Kong: Vice President, Recruitment
Download our 2018 Brochure
Hong Kong - Convictions In Less Than A Year After The Significant Controllers Register Law Came Into Force
On 7 January 2019, the Companies Registry published highlights of several prosecution cases regarding the convictions in November 2018 of twelve Hong Kong companies for having failed to keep and maintain their significant controllers registers ("SCR") in accordance with the Companies Ordinance (Cap 622) (the "CO"). All the companies convicted were fined.
Hong Kong - New HKEx Rules Spur Bumper Year In Hong Kong Capital Markets, But Lasting Impact Remains Unclear.
In April 2018, the Hong Kong Stock Exchange’s (HKEx) rule amendments permitting the listing of innovative, high-growth companies with dual-class share structures and pre-revenue biotech companies went into effect. The long-awaited amendments also facilitated the secondary listing in Hong Kong of Chinese companies with an existing listing on another stock exchange.